close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

DNORD.DK

275

-0.51%↓

Home・Aandelen Lijst・ROCKWOOL International A-S (Class B)
Search

ROCKWOOL International A-S (Class B)

Gesloten

174.1 4.67

Neutraal

Prijsupdate 23 mrt 2026, 15:54 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

160.5

Max

177.44

Belangrijke statistieken

By Trading Economics

Inkomsten

-482M

-332M

Verkoop

4M

967M

K/W

Sectorgemiddelde

242.432

61.065

EPS

0.34

Dividendrendement

0.33

Winstmarge

-34.303

Werknemers

12,524

EBITDA

-400M

-185M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-10.13% downside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.33%

2.23%

Volgende Winsten

19 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-7.6B

37B

Vorige openingsprijs

169.43

Vorige sluitingsprijs

174.1

ROCKWOOL International A-S (Class B) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

DJ

Lezen

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

DJ

Lezen

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

DJ

Lezen

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

DJ

Lezen

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

DJ

Lezen

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

DJ

Lezen

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

DJ

Lezen

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

DJ

Lezen

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

DJ

Lezen

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

DJ

Lezen

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

DJ

Lezen

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

DJ

Lezen

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

DJ

Lezen

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

DJ

Lezen

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

DJ

Lezen

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

DJ

Lezen

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

DJ

Lezen

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

DJ

Lezen

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

DJ

Lezen

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

DJ

Lezen

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

DJ

Lezen

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

DJ

Lezen

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

DJ

Lezen

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

DJ

Lezen

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

DJ

Lezen

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

23 mrt 2026, 20:50 UTC

Marktinformatie
Winsten
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

ROCKWOOL International A-S (Class B) Prognose

Koersdoel

By TipRanks

-10.13% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 1,650 DKK  -10.13%

Hoogste 1,650 DKK

Laagste 1,650 DKK

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor ROCKWOOL International A-S (Class B) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

1 ratings

0

Buy

1

Hold

0

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan ROCKWOOL International A-S (Class B) - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

DSV.DK

DSV PANALPINA A-S

1,537.5

↓-0.26%

MAERSK.A.DK

AP Moller - Maersk A-S (Class A)

16,500

↓-1.55%

VWS.DK

Vestas Wind Systems A-S

159.1

↑ +1.95%

DNORD.DK

D-S Norden A-S

275

↓-0.51%
help-icon Live chat